R P Byington

Summary

Affiliation: Wake Forest University School of Medicine
Country: USA

Publications

  1. ncbi request reprint Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project
    R P Byington
    Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
    Circulation 103:387-92. 2001
  2. ncbi request reprint Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy
    Robert P Byington
    Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
    Arterioscler Thromb Vasc Biol 22:1692-7. 2002
  3. ncbi request reprint Lessons learned from the prospective pravastatin pooling project
    Robert P Byington
    Department of Public Health Sciences, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157 1063, USA
    Curr Atheroscler Rep 6:366-74. 2004
  4. ncbi request reprint Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
    David C Goff
    Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1063, USA
    Am J Cardiol 99:4i-20i. 2007
  5. ncbi request reprint Pregnancy-related death and health care services
    Margaret A Harper
    Department of Obstetrics and Gynecology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA
    Obstet Gynecol 102:273-8. 2003
  6. ncbi request reprint Isradipine in prediabetic hypertensive subjects
    R P Byington
    Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1063, USA
    Diabetes Care 21:2103-10. 1998
  7. ncbi request reprint Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group
    R P Byington
    Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
    Circulation 100:e14-7. 1999
  8. pmc Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials
    David L Mount
    Wake Forest University School of Medicine, Winston Salem, NC, USA
    Clin Trials 6:416-29. 2009
  9. ncbi request reprint Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods
    John B Buse
    Division of Endocrinology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7172, USA
    Am J Cardiol 99:21i-33i. 2007
  10. ncbi request reprint Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project
    Marc A Pfeffer
    Brigham and Women s Hospital, Boston, MA 02115, USA
    Circulation 105:2341-6. 2002

Detail Information

Publications13

  1. ncbi request reprint Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project
    R P Byington
    Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
    Circulation 103:387-92. 2001
    ..Stroke is a leading cause of death and disability. Although clinical trials of the early lipid-lowering therapies did not demonstrate a reduction in the rates of stroke, data from recently completed statin trials strongly suggest benefit...
  2. ncbi request reprint Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy
    Robert P Byington
    Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
    Arterioscler Thromb Vasc Biol 22:1692-7. 2002
    ..In addition to the events trial, a carotid ultrasound substudy was established in 1993 to be conducted concurrently to determine whether hormone therapy affects the progression of the underlying atherosclerotic process...
  3. ncbi request reprint Lessons learned from the prospective pravastatin pooling project
    Robert P Byington
    Department of Public Health Sciences, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157 1063, USA
    Curr Atheroscler Rep 6:366-74. 2004
    ..Pravastatin was shown to safely reduce all-cause mortality, fatal and nonfatal coronary events, and stroke events in patients with a broad range of patient characteristics...
  4. ncbi request reprint Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
    David C Goff
    Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1063, USA
    Am J Cardiol 99:4i-20i. 2007
    ..The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial will test hypotheses to address these unanswered questions...
  5. ncbi request reprint Pregnancy-related death and health care services
    Margaret A Harper
    Department of Obstetrics and Gynecology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA
    Obstet Gynecol 102:273-8. 2003
    ..To examine the association between health care services variables and pregnancy-related death using a contemporary geographically defined population and enhanced methods for case identification...
  6. ncbi request reprint Isradipine in prediabetic hypertensive subjects
    R P Byington
    Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1063, USA
    Diabetes Care 21:2103-10. 1998
    ....
  7. ncbi request reprint Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group
    R P Byington
    Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
    Circulation 100:e14-7. 1999
    ..Few clinical trials have documented the efficacy of preventive treatment in asymptomatic women...
  8. pmc Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials
    David L Mount
    Wake Forest University School of Medicine, Winston Salem, NC, USA
    Clin Trials 6:416-29. 2009
    ..Comparing findings from separate trials is necessary to choose among treatment options, however differences among study cohorts may impede these comparisons...
  9. ncbi request reprint Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods
    John B Buse
    Division of Endocrinology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7172, USA
    Am J Cardiol 99:21i-33i. 2007
    ....
  10. ncbi request reprint Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project
    Marc A Pfeffer
    Brigham and Women s Hospital, Boston, MA 02115, USA
    Circulation 105:2341-6. 2002
    ..Therapeutic decisions regarding pharmacological therapy should be based on safety and tolerability as well as efficacy data. Clinical trials designed to assess efficacy are often insufficiently powered to generate reliable safety data...
  11. ncbi request reprint Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses
    Charles H Hennekens
    Mount Sinai Medical Center Miami Heart Institute, Department of Medicine and Epidemiology and Public Health, University of Miami School of Medicine, Boca Raton, FL 33432, USA
    Arch Intern Med 164:40-4. 2004
    ..Pravastatin has a predominantly delayed antiatherogenic effect, and aspirin has an immediate antiplatelet effect, raising the possibility of additive clinical benefits...
  12. ncbi request reprint The burden of treatment failure in type 2 diabetes: response to Brown et al
    Denise G Simons-Morton
    Diabetes Care 28:761-2. 2005
  13. doi request reprint Effects of intensive glucose lowering in type 2 diabetes
    Hertzel C Gerstein
    N Engl J Med 358:2545-59. 2008
    ....